hemostatic

(redirected from haemostasis)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

hemostatic

[¦hē·mə¦stad·ik]
(medicine)
An agent that arrests or checks bleeding, especially by shortening clotting time.
References in periodicals archive ?
The dos and don'ts of haemostasis and the haemostatic principles were discussed in depth and in detail, providing a well rounded theoretical as well as practical experience.
Most wound complications after minor breast surgery result from inadequate haemostasis with resultant secondary infection.
However, it is challenging for the surgeon as the newborn is likely to cry and move during the procedure and this may make the procedure more complicated than necessary making excision and adequate haemostasis difficult or impossible.
A five-year overview of this scoring system was published on behalf of the SSC on DIC of the ISTH in the March 2007 issue of Thrombosis and Haemostasis and concluded that a score of five or greater can identify overt DIC.
Australasian Society of Thrombosis and Haemostasis President Ross Baker said the study would take between two and three years to complete.
42nd Annual Meeting of the Society on Thrombosis & Haemostasis Research, February 25-28, 1998, KerckhoffKlinik, Sprudelhof 11, D-61231 Bad Nauheim, Germany.
The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within seven market categories - Haematology Reagents, Haemostasis, Haematology Rapid Tests, Immunohaematology, Haematology Analyzers and Haematology Cell Counters.
Today, at the International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress, Novo Nordisk announced the latest interim data from the guardian(TM)2 extension trial, which showed that in a phase 3 trial, NovoEight[sup.
Boldon-based IDS makes manual and automated diagnostic testing kits for clinical and research markets, while Stago is a producer of coagulation and haemostasis diagnostic kits and instrumentation.
The NISCHR Haemostasis Biomedical Research Unit now has 340 patients recruited on to blood clot studies.
Rebleeding was considered as a new period of bleeding after initial endoscopic haemostasis, based on clinical suspicion as defined by recurrent haematemesis and/or haematochezia, fresh blood in the nasogastric tube, a drop in haemoglobin or circulatory instability (as defined by a blood pressure below 90/60 mmHg and a heart rate above 100 beats/min).